2021 Consortium

Imaging Network Ontario (ImNO) is a group of interdisciplinary consortia focused on accelerating medical imaging innovation in Ontario. A list of ImNO consortia, their lead researchers and main sponsors can be found below. When applicable, links are provided to a consortium’s website. 

OICR Imaging Program

Program Co-Director: Dr. Aaron Fenster and and Martin Yaffe
Sponsor: Ontario Institute of Cancer Research (OICR)

The OICR Imaging Program (OICR IP) accelerates the translation of research into the development of new imaging innovations for earlier cancer detection, diagnosis and treatment through four major projects; probe development and commercialization, medical imaging instrumentation and software, pathology validation, and imaging for clinical trials.

OICR IP facilitates improved screening and treatment options for cancer patients by streamlining advances in medical imaging through the complex pipeline from discovery through clinical translation and ultimately to clinical use.

Development of Novel Therapies for Bone and Joint Diseases

Sponsor: Ontario Research Fund (ORF)

Lead Researcher:  Dr. David Holdsworth

Musculoskeletal disorders are the most common cause of severe long-term pain and physical disability, affecting hundreds of millions of people around the world. The economic burden is high; joint diseases cost the Ontario economy more than $2 billion per year. To reduce this disease burden, this Ontario Research Fund Research Excellence program focuses on the “Development of Novel Therapies for Bone and Joint Diseases,” including improved diagnostic imaging techniques and new approaches for image-guided therapy. A multidisciplinary team of imaging scientists, biomedical engineers, physical therapists, and orthopaedic surgeons work together on key research projects, including the development of new ways to post-process 3D MRI and CT data to guide surgery, dynamic imaging of moving joints (under load), and image-based design of “patient-specific” orthopaedic components.

Heart Failure: Prevention Through Early Detection Using New Imaging Methods

Sponsor: Ontario Research Fund (ORF)

Lead Researcher: Dr. Frank Prato

Consortium partners: Lawson Health Research Institute, Sunnybrook Research Institute and University of Ottawa Heart Institute

Ten percent of Ontarians over 60 have heart failure. One quarter will die within one year of diagnosis and almost all in ten years. Our LHRI/SRI/UOHI consortium is developing combined PET and MRI imaging methods for early diagnosis when treatment is still possible. The imaging methods developed are being commercialized and will benefit Ontario by improving the health of its citizens and creating new jobs.

Image-guided Device Interventions for Cardiovascular Disease

Sponsor: Ontario Research Fund (ORF)

Lead Researcher: Dr. Graham Wright

With advances in early identification and management of risk factors, combined with effective response to acute events, cardiovascular diseases have evolved from an acute killer to a chronic disease challenge. In recent years, there have been major advances in less invasive treatments. For minimally invasive device therapeutics, imaging and tracking technologies, along with the development of image-modality compatible tools, have unique roles in planning and guiding interventions, as well as monitoring functional results. In electropathophysiology, imaging will guide positioning of pacing devices, identify ablation targets, and direct therapy through fusion of device representations with maps of myocardial structure and function. Similar advances facilitate planning and guidance of both percutaneous and minimally invasive valve repair/replacement and catheter-based revascularization of chronic total occlusions. Researchers at Sunnybrook and Robarts Research Institutes, working with local, national, and multinational diagnostic imaging and interventional device companies, are advancing the state-of-the-art in image acquisition and analysis with ultrasound, MRI, x-ray, and CT methods, including the design of visualization platforms and associated communication and control interfaces for interventional guidance, facilitating fusion and manipulation of prior and real-time imaging and device information. The ultimate goal is more effective utilization of imaging to improve outcomes for those suffering from chronic ischemia, complex arrhythmias, and heart failure related to structural heart diseases.



Sponsor: NSERC Collaborative Research Training and Experience (CREATE) Program

Program Director: Dr. Alfred Yu

Ultrasound is well regarded for its broad application potential in both diagnostics and therapeutics. The N-GENIUS Program, hosted at the University of Waterloo, will aim to pioneer next-generation solutions for ultrasound imaging and therapy to address unmet clinical needs and, in turn, boost Canada's reputation as one of the global leaders in biomedical ultrasonics. N-GENIUS will also strive to cultivate a new generation of ultrasound R&D talent who will significantly contribute to Canada's ultrasound industry and scientific community.